|
V.A., Zhmurov, D.V. Zhmurov, S.A. Oskolkov, V.G. Yarkova, D.E Kovalchuk., S.V. Artem'eva
Impact of direct renin inhibitor on central hemodynamics parameters and thrombocytes structure and function in patients with chronic kidney disease and arterial hypertension
|
№3 / 2013
|
|
L. Yu. Milovanova, Yu. S. Milovanov, L.V. Kozlovskaya
Nephro- cardioprotective role of the Klotho protein circulating form in patients with chronic kidney disease
|
№3 / 2013
|
|
G.P. Arutiunov, L.G. Oganezova, A.V. Sokolova
Health centers: opportunities and perspectives in early diagnosis of heart failure and kidney involvement in patients with arterial hypertension
|
№1 / 2012
|
|
B.Z. Sirotin
Kidney in patients survived in hantaan and puumala virus-induced nephropathy
|
№2 / 2013
|
|
L.Yu. Milovanova, Yu.S. Milovanov, L.V. Kozlovskaya, N.A. Moukhin
Serum levels of morphogenetic proteins (fibroblast growth factor-23 and Klotho): clinical significance
|
№2 / 2013
|
|
T.E. Rudenko, I.M. Kutyrina, M.P. Vasylieva
Natriuretic peptides: diagnostic and prognostic significance in chronic kidney disease
|
№2 / 2013
|
|
N.A. Karpacheva, E.K. Petrosian
Early diagnosis of chronic kidney disease in teenagers in ambulatory practice
|
№1 / 2013
|
|
L.Yu. Milovanova, Yu.S. Milovanov, L.V. Kozlovskaya
Use of continuous erythropoietin receptor activator in treatment of anemia in patients with predialysis chronic kidney disease
|
№1 / 2013
|
|
А.Yu. Zemchenkov, R.P. Gerasimchuk, G.А. Zemchenkov, V.Yu. Ryasnyansky
Estimation of vascular calcification in hemodialysis patients in lateral X-tay film of abdominal aorta. Review and pilot clinical trial results
|
№1 / 2013
|
|
Yu.S. Milovanov, I.I. Aleksandrova, I.A. Dobrosmyslov
Violations of the nutritivny status and low-protein diet with keto-analogues of essential amino-acids in prevention of protein and energy deficiency in patients with chronic kidney disease
|
№1 / 2013
|
|
L.Yu. Milovanova, Yu.S. Milovanov, I.A. Dobrosmislov
Secondary hyperparathyreoidism in chronic kidney disease. Role of fibroblast growth factor-23 (FGF-23) and Klotho
|
№1 / 2013
|
|
Milovanova L.Yu., Milovanov Y.S., Dobrosmislov I.A., Moiseev S.V.
Perspectives of sevelamer in hyperphosphatemia treatment in patients with chronic kidney disease stage III–V
|
№5-6 / 2012
|
Русский
